Bioceltix S.A. (WSE:BCX)
Poland
· Delayed Price · Currency is PLN 101.00
-0.40 (-0.39%)
Apr 3, 2025, 2:45 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 499.34 million as of April 3, 2025. Its market cap has increased by 33.47% in one year.
Market Cap
499.34M
Enterprise Value
462.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
101.00
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 499.34M, an increase of 334.07%. That is a compound annual growth rate of 54.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 499.34M | 15.75% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NEUCA | 3.28B |
| Synektik Spólka Akcyjna | 1.83B |
| Voxel | 1.50B |
| Celon Pharma | 1.41B |
| Selvita | 695.67M |
| Ryvu Therapeutics | 647.36M |
| Centrum Medyczne ENEL-MED | 562.78M |
| Scope Fluidics | 528.83M |